Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Half: A Prospective Multi-Centre Phase II Clinical Trial Evaluating the Efficacy and Safety of Tyrosine Kinase Inhibitors' Discontinuation after Two-Step Dose Reduction in Patients with Chronic Myeloid Leukemia in Deep Molecular Remission

Daniela Žácková,Edgar Faber,Lukáš Stejskal,Michal Karas,Petra Bělohlávková,Hana Klamová,Olga Černá,Eduard Cmunt,Petra Čičátková,Lukáš Semerád,Tomáš Horňák,Anežka Kvetková,Jiřina Procházková,Jitka Rychlíčková,Radka Štěpánová,Adam Svobodník,Kateřina Machová Poláková,Ivana Ježíšková,Tomáš Jurček,Marek Borský

Blood（2021）

Cited 3|Views36
No score
Abstract
Background.
More
Translated text
Key words
chronic myeloid leukemia,tyrosine kinase inhibitors,tyrosine kinase,multi-centre,two-step
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined